Wellington Management Group LLP 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 07:34 am Sale | 2026-03-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Wellington Management Group LLP | 8,157,204 7.800% | -224,787 (-2.68%) | Filing |
| 2025-11-12 09:33 am Purchase | 2025-09-30 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Wellington Management Group LLP | 8,381,991 8.900% | 2,574,683 (+44.34%) | Filing |
| 2025-08-12 10:34 am Sale | 2025-06-30 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Wellington Management Group LLP | 5,807,308 6.200% | -1,143,259 (-16.45%) | Filing |
| 2025-02-10 10:25 am Purchase | 2024-12-31 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Wellington Management Group LLP | 6,950,567 7.500% | 2,490,876 (+55.85%) | Filing |
| 2024-11-08 10:52 am Purchase | 2024-09-30 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Wellington Management Group LLP | 4,459,691 5.570% | 1,214,586 (+37.43%) | Filing |
| 2024-02-08 10:11 am Purchase | 2023-12-29 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Wellington Management Group LLP | 3,245,105 4.860% | 440,620 (+15.71%) | Filing |
| 2023-02-06 2:51 pm Purchase | 2022-12-30 | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Wellington Management Group LLP | 2,804,485 5.210% | 2,804,485 (New Position) | Filing |